Recent News

• 05.07.2025 - Barinthus Bio Reports First Quarter 2025 Financial Results and Updates on Corporate Developments
• 03.20.2025 - Barinthus Bio Reports Full Year 2024 Financial Results and Updates on Corporate Developments
• 01.10.2025 - Barinthus Bio Announces Strategic Focus in Immunology and Inflammation (I&I) and Provides a Financial Update

Recent Filings

• 05.07.2025 - 8-K Current report
• 05.07.2025 - EX-99.1 EX-99.1
• 05.07.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 04.25.2025 - DEF 14A Other definitive proxy statements
• 04.25.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.25.2025 - ARS Annual Report to Security Holders
• 03.20.2025 - EX-99.1 EX-99.1
• 03.20.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.20.2025 - 8-K Current report
• 03.20.2025 - S-8 Securities to be offered to employees in employee benefit plans